Calibr at Scripps Research
Vadim Klyushnichenko, Ph.D., has significant experience in the pharmaceutical and biotechnology industries. Vadim currently holds the position of VP Pharmaceutical Development at Scripps Research, where they oversee the development and manufacturing activities across drug development programs. Prior to this, they served as VP Pharmaceutical Development and Quality at Calibr at Scripps Research, where they were responsible for process development, scale-up of API manufacturing, formulation, quality, and supply chain management.
Before joining Scripps Research, Dr. Klyushnichenko founded and served as Principal at Key Pharma LLC, a consulting firm specializing in drug development and manufacturing. During their time there, they supported biopharmaceutical companies in various capacities, including leading stage gate drug development initiatives, developing frameworks for portfolio management and strategic planning, and managing project planning and outsourcing.
Dr. Klyushnichenko also held leadership roles at Paragon Bioservices, Inc., Terapio, Coldstream Laboratories, Inc., Pfizer, Wyeth BioPharma, Epic Therapeutics (Baxter Healthcare), and Altus Pharmaceuticals. Throughout these roles, they gained extensive experience in areas such as process development, tech transfer, project management, analytical and formulation development, and regulatory compliance.
Overall, Dr. Klyushnichenko's work experience highlights their expertise in pharmaceutical development, manufacturing, project management, and cross-functional team leadership.
Vadim Klyushnichenko, Ph.D., has an extensive education history that spans several prestigious institutions.
Their education journey began at the Moscow Institute of Physics and Technology (MIPT) from 1984 to 1990, where they earned their B.S. and M.S.-Engineer degrees in Molecular Biotechnology. Following this, they pursued a Ph.D. in Analytical Biochemistry at the Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, RAS from 1990 to 1993.
In 1994, Klyushnichenko attended the Humboldt University in Berlin, Germany, as a DAAD Postdoc, specializing in Plant Physiology. Their academic pursuits then took him to Dusseldorf University in Germany from 1995 to 1997, where they were an Alexander von Humboldt Fellow, focusing on Biotechnology.
Continuing their education, Klyushnichenko completed the MBA Core Courses program at Harvard University in Cambridge, MA, USA, from 2000 to 2002, earning a Certificate in Management and Administration.
In addition to their formal education, Klyushnichenko has obtained various certifications. Vadim became a Certified Supply Chain Professional through APICS in 2014. Vadim also holds a Certificate in Management and Administration (CSS) from Harvard University. Furthermore, they have completed an Overview of Clinical Research Certificate from the Massachusetts Biotech Council (MBC) and a Project Management Professional (PMP) certification from the Project Management Institute.
Calibr at Scripps Research
1 followers
The California Institute for Biomedical Research (Calibr) is a first-of-its-kind, nonprofit translational research institute dedicated to accelerating the next generation of medicines. Affiliated with Scripps Research—among the most innovative institutes worldwide—we spearhead drug discovery from a steady flow of pioneering science. Our self-sustaining model encourages broad and bold exploration with far-reaching goals, yet rapid transition of our most successful, high-impact programs into the clinic. We pursue audacious and imaginative ideas—bridging scientific and technological advances to develop new medicines for unmet medical needs. Our pipeline programs range from cancer to infectious diseases and from discovery to early clinical trial stages, all aimed at preventing disease and healing humans around the world. We bring together leaders in research, drug development, and business to answer important biological questions and develop new interventions to treat, cure, and prevent disease. Our infrastructure and expertise extend from high-throughput screening and protein engineering to pharmacology and clinical development. Calibr’s research space includes a newly renovated 35,000 square foot facility in La Jolla, CA, which houses over 100 interdisciplinary scientists and staff with state-of-the-art instrumentation. This infrastructure, combined with Calibr’s drug discovery expertise, enables projects rooted in novel therapeutic mechanisms to progress from the laboratory through preclinical development and ultimately to the clinic through commercial, federal, or foundation partnerships.